Influence of intra-bone marrow infusion of peripheral hematopoietic stem cells on graft-versus-host disease.
- Author:
Yan-Zhi BI
1
;
Dong-Xiang ZENG
;
Gui-Feng SHENG
;
Yan ZHANG
;
Bao-An CHEN
Author Information
1. Department of Oncology, Changzhou Tumor Hospital, Suzhou University, Changzhou 213001, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Cyclophosphamide;
therapeutic use;
Female;
Graft vs Host Disease;
prevention & control;
Granulocyte Colony-Stimulating Factor;
therapeutic use;
Male;
Mice;
Mice, Inbred BALB C;
Mice, Inbred C57BL;
Models, Animal;
Peripheral Blood Stem Cell Transplantation;
adverse effects;
methods;
Recombinant Proteins;
Whole-Body Irradiation
- From:
Journal of Experimental Hematology
2007;15(5):1009-1012
- CountryChina
- Language:Chinese
-
Abstract:
This study was aimed to explore whether the graft-versus-host disease (GVHD) could be alleviated by intra-bone marrow (IBM) infusion of allogeneic hematopoietic stem cells. Female C57BL/6 mice as recipients received total body irradiation (TBI) 4 Gy on day 0, followed by injection of peripheral hematopoietic stem cells (1 x 10(7)) from mobilized male BALB/c with granulocyte-colony stimulating factor (rhG-CSF), and cyclophosphamide (200 mg/kg) was injected intraperitoneally two days later. The results showed that the incidence and severity of GVHD were more low and alleviative in group IBM-PBSCT than that in group TV-PBSCT (p < 0.05). Y chromosome of donor mice could be detected in the bone marrow of recipient mice. It is concluded that the method of intra-bone marrow infusion is superior to injection via the tail vein in the engraftment of hematopoietic stem cells in terms of stem cell homing while the frequency and severity of GVHD in allogeneic mice decrease.
